Updated:
Upcoming PharmaMar dividendNo signs of dividends from PharmaMar for this year have been detected.
PharmaMar (PHM) granted a dividend of 1 euros on July 10, 2026.
PharmaMar, which trades under the symbol PHMR, pays dividends to its shareholders every year, although it has been reported that part of its Board of Directors has proposed using this budget item for research and development.
It is a share with a general downward trend, although quite stable and with ample growth possibilities, with a dividend yield of approximately 1.8%, with payments being made once a year between April, May, June or July.
Join +33,000 investors who get notifications, analysis and news.
Payout Ratio PharmaMar Dividends
- Payout Ratio33.22%
- Retained Earnings66.78%
An appropriate payout ratio may vary depending on the industry, the company's growth stage and its financial health.
Dividend calendar of PharmaMar
There is no Dividend Calendar of PharmaMar defined for 2026.
For a company to have growing dividends by our standards, the annual dividend amount must have increased steadily for at least the last 5 years.
The company's dividend yield is compared to the industry average to determine its positioning.
Imagine you have a list of dividend yields for different companies in an industry. If you look for the "top 25% percentile", you will find a number. This number tells you that the top 25% of the companies with the highest dividends have a yield higher than that number. On the other hand, the "top 75% percentile" shows you another number, which tells you that 75% of the companies have a higher yield than that number, thus showing a more common and less high yield.
For a company to have stable dividends by our standards, it is vital that it has not had an annual decline of more than 10% over the previous year.
Dividend history of PharmaMar
In this table you can see the complete history:
| Year | Ex-Dividend | Amount | Total |
|---|---|---|---|
| 2026 |
07/08/2026 |
1 € |
1.0 € |
| 2025 |
06/25/2025 |
0.8 € |
0.8 € |
| 2024 |
06/12/2024 |
0.65 € |
0.65 € |
| 2023 |
06/07/2023 |
0.65 € |
0.65 € |
| 2022 |
07/13/2022 |
0.65 € |
0.65 € |
| 2021 |
04/28/2021 |
0.6 € |
0.6 € |
| 2020 |
06/26/2020 |
0.480002 € |
0.48 € |
Information about PharmaMar
PharmaMar is a Spanish company engaged in the pharmaceutical industry, specializing in research, development, creation and marketing of drugs made from marine resources, mainly to treat some types of cancer and mental illnesses such as Alzheimer's disease.
It was founded in 1986, although its beginnings came from Zeltia, which focused on the manufacture of drugs to prevent gynecological, cardiovascular, metabolic and hormonal diseases; it diversified in 1949 when it joined other laboratories and began to produce and package antibiotics, but it was not until 1986 that José María Fernández Sousa established the subsidiary PharmaMar.
Its creation was based on the understanding that most drugs are made from terrestrial components, shrubs, fungi, bacteria, among others.
Its main products include "Yondelis" trabectedin used to treat sarcoma and ovarian cancer, "Zepzelca" lurbinectedin recommended for lung cancer and "Aplidin" plitidepsin recommended for the treatment of multiple myeloma, as well as the commercialization of a rapid diagnostic kit for COVID-19 through its subsidiary Genomica.
Frequently asked questions about PharmaMar dividends
PharmaMar pays dividends on a Annual basis.
PharmaMar is listed on the Madrid Stock Exchange and is part of the Ibex Medium Cap.
PharmaMar has the Ticker or stock code PHM.
The CEO of PharmaMar in 2026 is Mr. Jose Maria Fernandez Sousa-Faro Ph.D..
The ISIN of PharmaMar is ES0169501022.
PharmaMar does not have a growing dividend program. Dividends have not shown a steady growth in the last 5 years.
Check the latest comments and participate in the live chat on PharmaMar stocks (PHM).
No comments yet. Be the first to join in.